Discovery of Serotonin-Producing Gut Bacteria Could Impact IBS Treatment
Research identifies two gut bacteria that produce serotonin, potentially influencing treatment strategies for IBS by regulating bowel movements.
Recent findings reveal that specific gut bacteria can synthesize serotonin, a crucial neurotransmitter for bowel regulation. This discovery may have significant implications for understanding and managing Irritable Bowel Syndrome (IBS).
In controlled experiments, these microbes demonstrated the ability to elevate serotonin levels in mice genetically modified to lack this chemical. This suggests a direct link between gut microbiota and serotonin production.
Additionally, researchers observed an increase in nerve cell density within the colon during these experiments, indicating a potential mechanism through which these bacteria could influence gastrointestinal function.